About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials in California | 706 Studies

Clinical Trials Ovarian CancerCalifornia

Ovarian Cancer Clinical Trials in California

Find 706 clinical trials for ovarian cancer near California. Connect with research centers in your area.

All Ovarian Cancer trials nationwide All trials in California

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 681-700 of 706 trials

RecruitingStudy of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid MalignanciesThis study will assess the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and preliminary efficacy of AZD9574 individually and in combination with anti-cancer…NCT05417594·La Jolla, California and 31 others CompletedCP-547,632 in Treating Patients With Recurrent or Persistent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerRATIONALE: CP-547,632 may stop the growth of tumor cells by blocking the enzymes necessary for their growth and by stopping blood flow to the tumor.NCT00096239·Los Angeles, California RecruitingAbemaciclib for the Treatment of Recurrent Ovarian or Endometrial CancerThis phase II trial studies how well abemaciclib works in treating patients with ovarian or endometrial cancer that has an activation of the CDK4/6 pathway and that has come back…NCT04469764·Los Angeles, California

Ovarian Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Approved for marketingExpanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.This is an open-label, single-arm, international, multicenter Multiple Patient Expanded Access Program (MPEAP).NCT03079687·Duarte, California and 12 others

CompletedTesting Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell Ovarian CancerThis phase II trial studies how well pembrolizumab and epacadostat work in treating patients with ovarian clear cell carcinoma that has come back (recurrent), remains despite…NCT03602586·Anchorage, Alaska and 362 others

Active not recruitingExperimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer TissuesThis phase I trial studies a new imaging technique called FAPi PET/CT to determine where and to which degree the FAPI tracer (68Ga-FAPi-46) accumulate in normal and cancer tissues…NCT04147494·Los Angeles, California

TerminatedPaclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian CarcinomaSince the mortality rates for patients with advanced ovarian carinoma are high, the most likely way to improve progression free and overall survival is with maximal "upfront"…NCT00976183·Newport Beach, California

CompletedGlycan Analysis in Diagnosing Cancer in Women With Ovarian Epithelial Cancer and in Healthy Female ParticipantsRATIONALE: New diagnostic procedures, such as glycan analysis, may be effective in finding ovarian epithelial cancer.NCT00628654·Sacramento, California

CompletedTrametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity CancerThis phase II/III trial studies how well trametinib works and compares it to standard treatment with either letrozole, tamoxifen, paclitaxel, pegylated liposomal doxorubicin, or…NCT02101788·Huntsville, Alabama and 500 others

CompletedEfficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)This is an open-label study of liposomal doxorubicin with or without volociximab for the treatment of subjects with advanced epithelial ovarian cancer or primary peritoneal cancer…NCT00635193·Anaheim, California and 38 others

CompletedRemote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported OutcomesThis study examines at-home monitoring of patient-generated phsyiologic health data and patient-reported outcomes.NCT04501913·Duarte, California

CompletedAminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the PeritoneumRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003523·Birmingham, Alabama and 64 others

CompletedA Study of MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube CancerThe purpose of the study is to assess the safety, tolerability, and efficacy of farletuzumab ecteribulin (MORAb-202) and compare it to Investigator's choice (IC) chemotherapy in…NCT05613088·Sacramento, California and 49 others

RecruitingA Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid MalignanciesThis research study is studying a new compound, AZD8205, as a possible treatment for advanced or metastatic solid tumours alone or in combination with anti-cancer agentsNCT05123482·Duarte, California and 66 others

TerminatedSafety/Efficacy Study of SGN-15 (Antibody-Drug Conjugate) Combined With Gemcitabine in Patients With Ovarian CancerThis is an open-label, randomized phase II trial comparing treatment with a monoclonal antibody (mAb) drug immunoconjugate, SGN-15, administered weekly in combination with weekly…NCT00051584·Tucson, Arizona and 5 others

Active not recruitingA Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor MalignanciesTransCon IL-2 β/γ is an investigational drug being developed for treatment of locally advanced or metastatic solid tumors.NCT05081609·Los Angeles, California and 67 others

RecruitingTesting Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian CancerThis phase III trial compares the effect of olaparib for one year versus two years, with or without bevacizumab, for the treatment of BRCA 1/2 mutated or homologous recombination…NCT06580314·Birmingham, Alabama and 694 others

Active not recruitingPembrolizumab in Treating Participants With Recurrent Ovarian CancerThis phase II trial studies how well pembrolizumab works in treating participants with ovarian cancer that has come back after previous treatment.NCT03732950·Los Angeles, California and 2 others

CompletedA Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid TumorsThe purpose of this open-label nonrandomized Phase 1/2 study is to evaluate INCB001158 in combination with chemotherapy in participants with advanced/metastatic solid tumors.NCT03314935·Birmingham, Alabama and 9 others

CompletedBevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the OvaryThis phase II trial studies how well bevacizumab works in treating patients with sex cord-stromal tumors of the ovary that have come back.NCT00748657·Los Angeles, California and 35 others

PreviousPage 35 of 36Next

Other Conditions in California

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia